Detalhe da pesquisa
1.
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 69, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650031
2.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230585
3.
NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab.
J Surg Oncol
; 126(8): 1494-1503, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111443
4.
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 22(1): 9, 2020 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969184
5.
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 21(1): 133, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796073
6.
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
Cancer
; 125(16): 2732-2746, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017664
7.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507135
8.
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
Breast Cancer Res Treat
; 152(2): 399-405, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26126970
9.
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
J Clin Oncol
; 41(29): 4643-4651, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478389
10.
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
Haematologica
; 97(2): 270-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058203
11.
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.
Clin Cancer Res
; 28(1): 163-174, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645649
12.
Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study.
Clin Cancer Res
; 27(6): 1612-1622, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203645
13.
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(8): 1225-1230, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196693
14.
Adrenal insufficiency as presenting feature of non-Hodgkin lymphoma.
Can J Urol
; 17(5): 5411-4, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974041
15.
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
NPJ Breast Cancer
; 6: 21, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32550266
16.
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.
Nat Rev Clin Oncol
; 17(12): 757-770, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632268
17.
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
Clin Cancer Res
; 14(21): 7088-94, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981007
18.
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10.
J Clin Oncol
; 37(29): 2601-2609, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442103
19.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523750
20.
Anaphylaxis after administration of ibritumomab tiuxetan for follicular non-hodgkin lymphoma.
Clin Nucl Med
; 33(2): 94-6, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18209526